EP2663649A4 - Direct detection of unamplified hepatitis c virus rna using unmodified gold nanoparticles - Google Patents

Direct detection of unamplified hepatitis c virus rna using unmodified gold nanoparticles

Info

Publication number
EP2663649A4
EP2663649A4 EP11855330.4A EP11855330A EP2663649A4 EP 2663649 A4 EP2663649 A4 EP 2663649A4 EP 11855330 A EP11855330 A EP 11855330A EP 2663649 A4 EP2663649 A4 EP 2663649A4
Authority
EP
European Patent Office
Prior art keywords
unamplified
hepatitis
gold nanoparticles
direct detection
virus rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11855330.4A
Other languages
German (de)
French (fr)
Other versions
EP2663649A1 (en
Inventor
Azzazy El-Badawy Hassan Mohamed El-Said
Abduo Sherif Mohamed Shawky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
American University in Cairo
Original Assignee
American University in Cairo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American University in Cairo filed Critical American University in Cairo
Publication of EP2663649A1 publication Critical patent/EP2663649A1/en
Publication of EP2663649A4 publication Critical patent/EP2663649A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP11855330.4A 2011-01-10 2011-01-10 Direct detection of unamplified hepatitis c virus rna using unmodified gold nanoparticles Withdrawn EP2663649A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/020676 WO2012096646A1 (en) 2011-01-10 2011-01-10 Direct detection of unamplified hepatitis c virus rna using unmodified gold nanoparticles

Publications (2)

Publication Number Publication Date
EP2663649A1 EP2663649A1 (en) 2013-11-20
EP2663649A4 true EP2663649A4 (en) 2014-08-27

Family

ID=46507350

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11855330.4A Withdrawn EP2663649A4 (en) 2011-01-10 2011-01-10 Direct detection of unamplified hepatitis c virus rna using unmodified gold nanoparticles

Country Status (3)

Country Link
EP (1) EP2663649A4 (en)
MY (1) MY166402A (en)
WO (1) WO2012096646A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6217495B2 (en) 2014-03-31 2017-10-25 ブラザー工業株式会社 Piezoelectric actuator
CN113151584A (en) * 2021-01-11 2021-07-23 南通大学 SARS-CoV-2 detection kit and detection method
CN115961060A (en) * 2022-08-22 2023-04-14 中国海洋大学 Primer probe group, kit, method and application for isothermal amplification detection of mycobacterium tuberculosis based on nanogold

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997037040A2 (en) * 1996-04-03 1997-10-09 Akzo Nobel N.V. Isolation and/or amplification of hepatitis c virus (hcv) nucleic acids from samples suspected to contain hcv
US20080311669A1 (en) * 2007-06-04 2008-12-18 Northwestern University Screening sequence selectivity of oligonucleotide-binding molecules using nanoparticle based colorimetric assay
WO2009131661A2 (en) * 2008-04-21 2009-10-29 Dicerna Pharmaceuticals, Inc. Methods and compositions for the specific inhibition of hepatitis c virus (hcv) by double-stranded rna

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083482A (en) * 1999-05-11 2000-07-04 Icn Pharmaceuticals, Inc. Conformationally locked nucleosides and oligonucleotides
JP5138230B2 (en) * 2004-01-07 2013-02-06 サード・ウェーブ・テクノロジーズ・インク Method for determining the genotype of hepatitis C virus

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997037040A2 (en) * 1996-04-03 1997-10-09 Akzo Nobel N.V. Isolation and/or amplification of hepatitis c virus (hcv) nucleic acids from samples suspected to contain hcv
US20080311669A1 (en) * 2007-06-04 2008-12-18 Northwestern University Screening sequence selectivity of oligonucleotide-binding molecules using nanoparticle based colorimetric assay
WO2009131661A2 (en) * 2008-04-21 2009-10-29 Dicerna Pharmaceuticals, Inc. Methods and compositions for the specific inhibition of hepatitis c virus (hcv) by double-stranded rna

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BAPTISTA PEDRO ET AL: "Gold nanoparticles for the development of clinical diagnosis methods", ANALYTICAL AND BIOANALYTICAL CHEMISTRY, SPRINGER, BERLIN, DE, vol. 391, no. 3, 1 June 2008 (2008-06-01), pages 943 - 950, XP002497473, ISSN: 1618-2650, [retrieved on 20071221], DOI: 10.1007/S00216-007-1768-Z *
JELANI GRIFFIN ET AL: "Size- and Distance-Dependent Nanoparticle Surface-Energy Transfer (NSET) Method for Selective Sensing of Hepatitis C Virus RNA", CHEMISTRY - A EUROPEAN JOURNAL., vol. 15, no. 2, 26 November 2008 (2008-11-26), WEINHEIM, DE, pages 342 - 351, XP055116087, ISSN: 0947-6539, DOI: 10.1002/chem.200801812 *
SANAA EISSA ET AL: "Direct detection of unamplified hepatoma upregulated protein RNA in urine using gold nanoparticles for bladder cancer diagnosis", CLINICAL BIOCHEMISTRY, vol. 47, no. 1-2, 1 January 2014 (2014-01-01), pages 104 - 110, XP055129057, ISSN: 0009-9120, DOI: 10.1016/j.clinbiochem.2013.10.022 *
See also references of WO2012096646A1 *
SHAWKY S M ET AL: "Direct detection of unamplified hepatitis C virus RNA using unmodified gold nanoparticles", CLINICAL BIOCHEMISTRY, ELSEVIER INC, US, CA, vol. 43, no. 13-14, 1 September 2010 (2010-09-01), pages 1163 - 1168, XP027248991, ISSN: 0009-9120, [retrieved on 20100801] *

Also Published As

Publication number Publication date
WO2012096646A9 (en) 2012-08-30
WO2012096646A1 (en) 2012-07-19
MY166402A (en) 2018-06-25
EP2663649A1 (en) 2013-11-20

Similar Documents

Publication Publication Date Title
HRP20181564T1 (en) Compositions and methods for inhibiting gene expression of hepatitis b virus
ZA201308419B (en) Detection of nucleic acids using unmodified gold nanoparticles
HUS1700002I1 (en) Inhibitors of hepatitis c virus replication
IL224369B (en) Combinations of hepatitis c virus inhibitors
HK1185763A1 (en) Inhibitors of hepatitis c virus
IL221033A0 (en) Hepatitis c virus inhibitors
EP2575819A4 (en) Hepatitis c virus inhibitors
HK1163067A1 (en) Hepatitis c virus inhibitors
HK1161245A1 (en) Hepatitis c virus inhibitors
EP2512480A4 (en) Hepatitis c virus inhibitors
EP2475254A4 (en) Hepatitis c virus inhibitors
EP2475256A4 (en) Hepatitis c virus inhibitors
EP2400846A4 (en) Hepatitis c virus inhibitors
IL224298A (en) Hepatitis c virus inhibitors
EP2603080A4 (en) Hepatitis c virus inhibitors
ZA201105349B (en) Methods for amplifying hepatitis c virus nucleic acids
EP2688592A4 (en) Compositions and methods to immunize against hepatitis c virus
EP2651906A4 (en) Inhibitors of hepatitis c virus polymerase
EP2484378A4 (en) Hepatitis c virus vaccine composition
EP2756102A4 (en) Detection of viral infection
EP2663649A4 (en) Direct detection of unamplified hepatitis c virus rna using unmodified gold nanoparticles
EP2626426A4 (en) Hepatitis c virus gene
EP2716757A4 (en) Mutant replicon derived from genome of hepatitis c virus j6cf strain
SG10201602184TA (en) Treatment of hepatitis c virus infection with alisporivir
GB201114710D0 (en) Treatment of hepatitis c

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130812

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20140728

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20060101AFI20140722BHEP

17Q First examination report despatched

Effective date: 20160121

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160802